HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guo-Tong Xu Selected Research

Glyoxal (Ethanedial)

1/2022Enhancing fractalkine/CX3CR1 signalling pathway can reduce neuroinflammation by attenuating microglia activation in experimental diabetic retinopathy.
1/2022An in vitro cell model to study microglia activation in diabetic retinopathy.
1/2018miR-365 promotes diabetic retinopathy through inhibiting Timp3 and increasing oxidative stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guo-Tong Xu Research Topics

Disease

18Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 05/2009
9Inflammation (Inflammations)
01/2022 - 10/2009
7Hypoxia (Hypoxemia)
01/2022 - 04/2012
6Neoplasms (Cancer)
01/2021 - 01/2010
6Retinal Degeneration
01/2020 - 04/2013
4Proliferative Vitreoretinopathy
01/2021 - 01/2018
4Macular Degeneration (Age-Related Maculopathy)
01/2021 - 12/2018
3Macular Edema
06/2022 - 01/2010
3Fibrosis (Cirrhosis)
01/2021 - 12/2012
3Blindness (Hysterical Blindness)
01/2021 - 07/2009
3Retinal Diseases
01/2021 - 12/2018
2Neuroinflammatory Diseases
01/2022 - 01/2021
2Wounds and Injuries (Trauma)
07/2018 - 01/2016
2Infections
07/2018 - 05/2014
2Carcinogenesis
01/2018 - 11/2017
2Gliosis
01/2018 - 01/2011
2Neuroblastoma
11/2017 - 01/2017
2Cataract (Cataracts)
01/2011 - 01/2010
1Central Nervous System Diseases (CNS Diseases)
01/2022
1Insulin Resistance
11/2021
1Edema (Dropsy)
04/2021
1Papilledema
04/2021
1Hypersensitivity (Allergy)
01/2021
1Systemic Scleroderma (Systemic Sclerosis)
01/2021
1Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
01/2021
1Corneal Diseases (Corneal Disease)
01/2021
1Hepatocellular Carcinoma (Hepatoma)
01/2021
1Necrosis
07/2018
1Epiretinal Membrane (Epiretinal Membranes)
01/2018
1Disease Progression
01/2017
1Pathologic Neovascularization
01/2017
1Multiple Sclerosis
09/2015
1Dry Eye Syndromes (Dry Eye Syndrome)
09/2015
1Gastritis
06/2015
1Infarction (Infarctions)
05/2015
1Stroke (Strokes)
05/2015
1Mycoses (Diseases, Fungus)
10/2014

Drug/Important Bio-Agent (IBA)

8Retinaldehyde (Retinal)IBA
01/2022 - 07/2009
6CytokinesIBA
01/2022 - 01/2011
6Retinal Pigments (Pigments, Visual)IBA
01/2021 - 01/2018
6ErythropoietinFDA Link
01/2021 - 01/2010
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2022 - 01/2010
4Interleukin-6 (Interleukin 6)IBA
07/2018 - 04/2013
3Glyoxal (Ethanedial)IBA
01/2022 - 01/2018
3Streptozocin (Streptozotocin)FDA Link
01/2022 - 10/2013
3Pharmaceutical PreparationsIBA
01/2021 - 09/2015
3Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2015
2MelatoninIBA
01/2022 - 01/2021
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2022 - 01/2022
2Glia Maturation Factor (GMF)IBA
01/2022 - 01/2021
2Interleukin-10 (Interleukin 10)IBA
01/2021 - 06/2015
2Phosphotransferases (Kinase)IBA
11/2017 - 01/2017
2Exenatide (Byetta)FDA Link
01/2011 - 05/2009
1liproxstatin-1IBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022
1ColforsinIBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1InterleukinsIBA
01/2022
1Chemokine CX3CL1IBA
01/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022
1HDL CholesterolIBA
11/2021
1OF 743IBA
11/2021
1HDL LipoproteinsIBA
11/2021
1Ranibizumab (Lucentis)FDA Link
04/2021
1Amyloid (Amyloid Fibrils)IBA
01/2021
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Matrix Metalloproteinases (MMPs)IBA
01/2021
1Conditioned Culture MediaIBA
01/2021
1Dopamine (Intropin)FDA LinkGeneric
01/2021
1Mitochondrial DNA (mtDNA)IBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Actin Depolymerizing Factors (Cofilins)IBA
01/2021
1cadherin 5IBA
10/2020
1Metformin (Glucophage)FDA LinkGeneric
01/2020
1protein kinase modulatorIBA
01/2020
1N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA
01/2020
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2020
1OccludinIBA
12/2019
1MicroRNAs (MicroRNA)IBA
11/2019
1Tumor Biomarkers (Tumor Markers)IBA
07/2018
1sodium iodateIBA
01/2018
1fucoidanIBA
01/2018
1tyrosine receptor (receptor, tyrosine)IBA
11/2017
1regorafenibIBA
11/2017
1Adenosine Triphosphatases (ATPase)IBA
01/2017
1alectinibIBA
01/2017
1Anaplastic Lymphoma KinaseIBA
01/2017
1Bromodeoxyuridine (BrdU)IBA
01/2016
1Zinc Transporter 8IBA
12/2015
1Fingolimod Hydrochloride (FTY720)FDA Link
09/2015
1ChemokinesIBA
06/2015
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2015
1triphenyltetrazoliumIBA
05/2015
1Pattern Recognition ReceptorsIBA
10/2014
1dectin 1IBA
10/2014

Therapy/Procedure

11Therapeutics
12/2021 - 01/2010
4Transplantation
01/2020 - 05/2015
3Intravitreal Injections
01/2018 - 01/2010
1Aftercare (After-Treatment)
06/2015